United States
Germany
Japan
United Kingdom
China
QPRT mouse monoclonal antibody, clone OTI1C10 (formerly 1C10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
QPRT mouse monoclonal antibody, clone OTI7A8 (formerly 7A8)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI4B3 (formerly 4B3)
| Applications | FC, WB |
| Reactivities | Human |
QPRT mouse monoclonal antibody, clone OTI4E6 (formerly 4E6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
QPRT mouse monoclonal antibody, clone OTI1C10 (formerly 1C10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI4E5 (formerly 4E5)
| Applications | FC, IF, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI2H4 (formerly 2H4)
| Applications | FC, IF, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI3B3 (formerly 3B3)
| Applications | FC, IF, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI4B4 (formerly 4B4)
| Applications | FC, WB |
| Reactivities | Human |
QPRT mouse monoclonal antibody, clone OTI7A8 (formerly 7A8)
| Applications | FC, IHC, WB |
| Reactivities | Human |
QPRT mouse monoclonal antibody, clone OTI4E6 (formerly 4E6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI4E5 (formerly 4E5)
| Applications | FC, IF, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI4B3 (formerly 4B3)
| Applications | FC, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI3B3 (formerly 3B3)
| Applications | FC, IF, WB |
| Reactivities | Human |
Anti-QPRT mouse monoclonal antibody, clone OTI2H4 (formerly 2H4)
| Applications | FC, IF, WB |
| Reactivities | Human |
